サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：糞便免疫化学的診断検査（FIT）市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年
市場調査レポート
商品コード
1301428

糞便免疫化学的診断検査（FIT）市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年

Fecal Immunochemical Diagnostic Test (FIT) Market (Product: Kits & Reagents, Analyzers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 147 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
糞便免疫化学的診断検査（FIT）市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年
出版日: 2023年05月15日
発行: Transparency Market Research
ページ情報: 英文 147 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

糞便免疫化学的診断検査（FIT）市場- レポートの範囲

世界の糞便免疫化学的診断検査（FIT）市場に関するTMRの調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界市場の収益を提供します。また、2023年から2031年までの世界市場の複合年間成長率（CAGR %）も掲載しています。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、糞便免疫化学的診断検査（FIT）市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界の糞便免疫化学的診断検査（FIT）市場の競合情勢を詳しく掘り下げています。世界の糞便免疫化学的診断検査（FIT）市場で活動している主要プレーヤーが特定され、これらはさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の糞便免疫化学的診断検査（FIT）市場のプレーヤーの属性です。

目次

第1章 序文

第2章 仮定と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017～2031年

第5章 主要な洞察

  • 主要国の世界の病気の有病率と罹患率
  • 規制シナリオ
  • 価格分析
  • COVID-19のパンデミックが業界に与える影響

第6章 世界市場の分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場金額予測：製品タイプ別、2017-2031
    • キットと試薬
    • アナライザー
    • その他
  • 市場魅力分析：製品タイプ別

第7章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場金額予測：エンドユーザー別、2017-2031
    • 病院と診断研究所
    • 専門クリニック
    • ホームケア設定
    • 調査機関
  • 市場魅力分析：エンドユーザー別

第8章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析：地域別

第9章 北米市場の分析と予測

第10章 欧州市場の分析と予測

第11章 アジア太平洋市場の分析と予測

第12章 ラテンアメリカ市場の分析と予測

第13章 中東およびアフリカ市場の分析と予測

第14章 競合情勢

  • 市場企業- 競合マトリックス（企業の階層および規模別）
  • 市場シェア分析：企業別、2022年
  • 企業プロファイル
    • Quest Diagnostics Incorporated
    • Sentinel CH. SpA
    • FUJIFILM Corporation
    • Quidel Corporation
    • Danaher（Beckman Coulter, Inc.）
    • Eiken Chemical Co., Ltd.
    • Freenome Holdings, Inc.
    • Immunostics, Inc.
    • BTNX, Inc.
    • Biohit Oyj
図表

List of Tables

  • Table 01: Global Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 03: Global Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 04: North America Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 05: North America Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 06: North America Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 07: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 08: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 09: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 10: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 11: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 12: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 18: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Fecal Immunochemical Diagnostic Test (FIT) Market Value Share, by Product Type, 2022
  • Figure 03: Global Fecal Immunochemical Diagnostic Test (FIT) Market Value Share, by End-user, 2022
  • Figure 04: Global Fecal Immunochemical Diagnostic Test (FIT) Market Value Share, by Region, 2022
  • Figure 05: Global Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 06: Global Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Mn), by Kits & Reagents, 2017-2031
  • Figure 07: Global Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Mn), by Analyzers, 2017-2031
  • Figure 08: Global Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 09: Global Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 10: Global Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 11: Global Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Mn), by Hospitals & Diagnostic Laboratories, 2017-2031
  • Figure 12: Global Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Mn), by Specialty Clinics, 2017-2031
  • Figure 13: Global Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Mn), by Home Care Settings, 2017-2031
  • Figure 14: Global Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Mn), by Research Institutes, 2017-2031
  • Figure 15: Global Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 16: Global Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 17: Global Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 18: North America Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 19: North America Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 20: North America Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 21: North America Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 22: North America Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 23: North America Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 24: North America Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 25: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 26: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 27: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 28: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 29: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 30: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 31: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 32: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 33: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 34: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 35: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 36: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 37 Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 38: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 39: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 40: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 41: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 42: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 43: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 44: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 45: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 46: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 47: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 48: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 49: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 50: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 51: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 52: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Attractiveness Analysis, by End-user, 2023-2031
目次
Product Code: TMRGL80238

Fecal Immunochemical Diagnostic Test (FIT) Market - Scope of Report

TMR's report on the global Fecal Immunochemical Diagnostic Test (FIT) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Fecal Immunochemical Diagnostic Test (FIT) market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Fecal Immunochemical Diagnostic Test (FIT) market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Fecal Immunochemical Diagnostic Test (FIT) market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Fecal Immunochemical Diagnostic Test (FIT) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Fecal Immunochemical Diagnostic Test (FIT) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Fecal Immunochemical Diagnostic Test (FIT) market.

The report delves into the competitive landscape of the global Fecal Immunochemical Diagnostic Test (FIT) market. Key players operating in the global Fecal Immunochemical Diagnostic Test (FIT) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Fecal Immunochemical Diagnostic Test (FIT) market profiled in this report.

Key Questions Answered in Global Fecal Immunochemical Diagnostic Test (FIT) Market Report:

  • What is the sales/revenue generated by Fecal Immunochemical Diagnostic Test (FIT) across all regions during the forecast period?
  • What are the opportunities in the global Fecal Immunochemical Diagnostic Test (FIT) market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Fecal Immunochemical Diagnostic Test (FIT) Market - Research Objectives and Research Approach

The comprehensive report on the global Fecal Immunochemical Diagnostic Test (FIT) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Fecal Immunochemical Diagnostic Test (FIT) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Fecal Immunochemical Diagnostic Test (FIT) market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Fecal Immunochemical Diagnostic Test (FIT) Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Disease Prevalence & Incidence Rate globally with key countries
  • 5.2. Regulatory Scenario
  • 5.3. Pricing Analysis
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Kits & Reagents
    • 6.3.2. Analyzers
    • 6.3.3. Others
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Hospitals & Diagnostic Laboratories
    • 7.3.2. Specialty Clinics
    • 7.3.3. Home Care Settings
    • 7.3.4. Research Institutes
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Product Type, 2017-2031
    • 9.2.1. Kits & Reagents
    • 9.2.2. Analyzers
    • 9.2.3. Others
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals & Diagnostic Laboratories
    • 9.3.2. Specialty Clinics
    • 9.3.3. Home Care Settings
    • 9.3.4. Research Institutes
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product Type
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2031
    • 10.2.1. Kits & Reagents
    • 10.2.2. Analyzers
    • 10.2.3. Others
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals & Diagnostic Laboratories
    • 10.3.2. Specialty Clinics
    • 10.3.3. Home Care Settings
    • 10.3.4. Research Institutes
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product Type
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Kits & Reagents
    • 11.2.2. Analyzers
    • 11.2.3. Others
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Hospitals & Diagnostic Laboratories
    • 11.3.2. Specialty Clinics
    • 11.3.3. Home Care Settings
    • 11.3.4. Research Institutes
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product Type
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Kits & Reagents
    • 12.2.2. Analyzers
    • 12.2.3. Others
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Hospitals & Diagnostic Laboratories
    • 12.3.2. Specialty Clinics
    • 12.3.3. Home Care Settings
    • 12.3.4. Research Institutes
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product Type
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Kits & Reagents
    • 13.2.2. Analyzers
    • 13.2.3. Others
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Hospitals & Diagnostic Laboratories
    • 13.3.2. Specialty Clinics
    • 13.3.3. Home Care Settings
    • 13.3.4. Research Institutes
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Product Type
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2022
  • 14.3. Company Profiles
    • 14.3.1. Quest Diagnostics Incorporated
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Strategic Overview
    • 14.3.2. Sentinel CH. SpA
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Strategic Overview
    • 14.3.3. FUJIFILM Corporation
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Strategic Overview
    • 14.3.4. Quidel Corporation
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Strategic Overview
    • 14.3.5. Danaher (Beckman Coulter, Inc.)
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Strategic Overview
    • 14.3.6. Eiken Chemical Co., Ltd.
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Strategic Overview
    • 14.3.7. Freenome Holdings, Inc.
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Strategic Overview
    • 14.3.8. Immunostics, Inc.
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Strategic Overview
    • 14.3.9. BTNX, Inc.
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. SWOT Analysis
      • 14.3.9.4. Strategic Overview
    • 14.3.10. Biohit Oyj
      • 14.3.10.1. Company Overview
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. SWOT Analysis
      • 14.3.10.4. Strategic Overview